Past Issues

  1. Home
  2. Past Issues

Drug Eluting Stent (DES)

Drug Eluting Stent, which is put in the coronary artery of patients with aischemic heart disease, is quickly becoming an alternative to a metallic stent.

However, the long-term survival rate for delayed thrombosis has become an international issue.

August 9th 2007,we requested to MHLW and Johnson & Johnson that clinical use of the drug be suspended, because of a basic problem regarding safety and effectiveness, such as proper approval, conditions required for anti-thrombotic medicines which is jointly used, application settings and the replaceability of other treatment methods.


  • YAKUGAI Ombudsperson
  • Tie-up Group

No Related Information

Table Of Contents